Infectious Diseases Society of America 2023 guidance on the treatment of antimicrobial resistant gram-negative infections
Abstract Background The Infectious Diseases Society of America is committed to providing
up-to-date guidance on the treatment of antimicrobial-resistant infections. This guidance …
up-to-date guidance on the treatment of antimicrobial-resistant infections. This guidance …
Novel Siderophore Cephalosporin and Combinations of Cephalosporins with β-Lactamase Inhibitors as an Advancement in Treatment of Ventilator-Associated …
S Viscardi, E Topola, J Sobieraj, A Duda-Madej - Antibiotics, 2024 - mdpi.com
In an era of increasing antibiotic resistance among pathogens, the treatment options for
infectious diseases are diminishing. One of the clinical groups especially vulnerable to this …
infectious diseases are diminishing. One of the clinical groups especially vulnerable to this …
Bithionol Restores Sensitivity of Multidrug-Resistant Gram-Negative Bacteria to Colistin with Antimicrobial and Anti-biofilm Effects
W Guo, Y Liu, Z Yao, H Zhou, X Wang… - ACS Infectious …, 2023 - ACS Publications
Being among the few last-resort antibiotics, colistin (COL) has been used to treat severe
infectious diseases, such as those caused by multidrug-resistant Gram-negative bacteria …
infectious diseases, such as those caused by multidrug-resistant Gram-negative bacteria …
Novel Antibiotics for Gram-Negative Nosocomial Pneumonia
MP Almyroudi, A Chang, I Andrianopoulos… - Antibiotics, 2024 - mdpi.com
Nosocomial pneumonia, including hospital-acquired pneumonia and ventilator-associated
pneumonia, is the leading cause of death related to hospital-acquired infections among …
pneumonia, is the leading cause of death related to hospital-acquired infections among …
Multidrug-resistant Pseudomonas aeruginosa: A pathogen with challenging clinical management
MM Montero, JP Horcajada - Enfermedades infecciosas y …, 2023 - pubmed.ncbi.nlm.nih.gov
Multidrug-resistant Pseudomonas aeruginosa: A pathogen with challenging clinical
management Multidrug-resistant Pseudomonas aeruginosa: A pathogen with challenging …
management Multidrug-resistant Pseudomonas aeruginosa: A pathogen with challenging …
Fattori di rischio ed evoluzione clinica delle batteriemie da Pseudomonas aeruginosa: uno strumento di previsione della mortalità nei reparti di medicina interna.
L Casini - 2024 - unire.unige.it
Obiettivo: lo studio valuta le caratteristiche cliniche ei fattori di rischio per la mortalità a 30
giorni nei pazienti ricoverati nei reparti di medicina interna con batteriemia da P …
giorni nei pazienti ricoverati nei reparti di medicina interna con batteriemia da P …
Epidemiology and Treatment of infections caused by extensively drug-resistant Pseudomonas aeruginosa. Clinical and microbiological impact of the new …
I Lopez Montesinos - 2023 - ddd.uab.cat
L'objectiu principal d'aquesta tesi és avaluar l'epidemiologia clínica i les diferents opcions
terapèutiques pel que fa al tractament de Pseudomones aeruginosa extremadament …
terapèutiques pel que fa al tractament de Pseudomones aeruginosa extremadament …